Wed, Jul 23, 2014, 9:53 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Amgen, Inc. (AMGN) Message Board

cabillhoward 14 posts  |  Last Activity: Jan 23, 2013 10:13 PM Member since: Jan 7, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Vasella Steps Down

    by thehardrightedge Jan 23, 2013 11:30 AM
    cabillhoward cabillhoward Jan 23, 2013 10:13 PM Flag

    On December 13, 2012 one day before the Connecticut shootings, a warning was issued to Vanda Pharmaceutical Inc. the manufacturer of Fanapt, from The Committee for Medicinal Product for Human(CHMP) who advised against marketing authorization and stated the risk surpassed the rewards. Adam Lanza was on Fanapt. Side effects reported were violent outburst and fits of rage.


    The days that followed the elementary school shootings in Connecticut were devastating for this country and only days before Christmas. A Christmas that would never come for a town in mourning after their little children and their teachers were gunned down. It's one of the most heartbreaking moments in this country's history. This isn't the kind of things that happened when I was growing up, teachers and children were not gunned down like animals in our schools. These kind of random acts of violence we see occurring by the hands of children have become common and we need to find answers.

    We must find out why children have become so violent. The answer is actually right in front of our faces but, deliberately kept out of the mainstream media. Ritalin was heavily introduced into the market for children that were hyper and in the 1990's the widespread use of Psychotropic drugs rose 700%
    Every shooter starting from Columbine was taking psychotropic drugs that had known serious side effects including fits of rage. The warnings issued were not only ignored by the Pharmaceutical companies but were deliberately covered up.
    Pharmaceutical companies have conducted fraudulent, painful experiments 0n animals knowing the animal is not a reliable model for a human being. If the drug is considered safe on a primate or other species it's considered safe for humans. This has resulted in disastrous effects. We do not share 100% of the same DNA as a primate therefore a primate should never be used as a human model.
    Primates waste away in sheer terror in laboratories as I write this. The test they will endure will be only used as a cover up for the pharmaceutical companies to shove their dangerous drugs as quickly as possible into the market.

    Data Fabrication is so widespread there is a name for it, in the United States it is called "Dry Labeling" in Japan it's called "Making" false reports are given stating the drug is safe and effective for humans after being tested on primates and other species.

    Novartis the distributer and owner of Fanapt was the company also behind what was called the worst disaster in medical history, baboon and pig hearts removed from the animal and surgically implanted into a human. In many cases these animals were fully conscience in every case both animal and human died. Covance, Huntingdon Life Sciences, are directly connected with Novartis. The USDA violations against animals are shocking. This a story of modern day witchdoctors at it's best. the CEO of Novartis and his staff has never been held accountable. The warning the distributer and manufacturer were issued clearly stated "the risk of taking Fanapt were not worth the rewards" Also treatment or use longer than five weeks on a human was never established. Fanapt was released by these companies knowing it caused psychotic rages. It's not known if Adam Lanza was diagnosed at birth with this mental disorder or if he simply had ADHD and was given a steady stream of drugs and later became schizophrenic.


    These psychotropic drugs were known to cause serious side effects including aggression, and delusion, Hostility, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, delirium, polydipsia psychogenic, impulse-control disorder, and major depression. Demand Vanda, Novartis and all of the companies that distributed these drugs to the children and young adults that shot up our schools, malls, movie theaters where so many have died, be held accountable for their actions.

    Do not allow your children to be forced to take psychotropic drugs under any circumstances this is not going to cure your child. Mineral and chemical deficiencies can be cured. In cases of Dementia it was determined simply adding potassium to the diets of those effected cured the symptoms.
    Testing your child for these deficiencies and supplying them with the necessary nutrients and trace minerals they are missing as well as testing for heavy metals can have the necessary results you are seeking. By refusing to give your child psychotropic drugs you may stop another tragedy.

    These drugs are dangerous and as the result have caused people including our children to become dangerous. Until we all come to the realization this is not about gun control it's about the mis-use of psychotropic drugs being prescribed to us and our children.

    NY is the only state that considered a bill to ban the long term use of psychotropic drugs.

  • By Ed Silverman // January 9th, 2013 // 12:37 pm
    Many people may complain about the gap between ceo compensation and the rest of the world, but the Swiss are doing more than grumbling. A nationwide vote is planned for March 3 on an initiative that would look to level the playing field by giving citizens a chance to decide whether shareholders should have more say in executive compensation, SwissInfo reports.
    The initiative calls for a new article in the Swiss constitution designed to regulate Swiss companies listed on the stock exchange and to increase the decision-making power of their shareholders, SwissInfo writes, adding that the initiative completely bans golden handshakes and advance payments.
    We mention this because two Novartis (NVS) execs – ceo Joe Jimenez and chairman Dan Vasella – are held up as two prime examples in which the compensation gap is huge. The lowest-paid Novartis employee would have to work 266 years to earn the $17.1 million that Jimenez received in 2011, according to the trade union Travail Suisse in its annual survey.
    In third place is Vasella, whose compensation would have required the lowest-paid Novartis employee to work 229 years to earn what he was paid in 2011, according to SwissInfo. Vasella, you may recall, has previously been criticized over his compensation, after heading the ranking of top earners between 2005 and 2009.
    Last year at this time, we noted that Ethos, a shareholder activist group, complained that his $14.8 million compensation in 2011 was inappropriate, given that Novartis profit fell 7 percent. Meanwhile, the drugmaker had recently announced plans to eliminate thousands of jobs, including hundreds of positions in Switzerland, where Novartis is based (back story).
    “There is no economic justification for exorbitant executive salaries,” Jean-Jacques Friboulet, a professor for economic ethics at Fribourg University tells SwissInfo. The economy cannot regulate itself and that is why he backs the initiative “against rip-off salaries.”

  • By Ed Silverman // January 3rd, 2013 // 8:54 am
    From November 1990 to December 2005, Jill Osciecki was a sales representative for Amgen , mostly in the Midwestern US, where she promoted the Aranesp medicine that is used to treat anemia caused by chemotherapy and chronic kidney disease. However, she was one of a handful of Amgen reps who eventually chafed at allegedly illegal marketing tactics that have now become a familiar refrain in the lore of pharmaceutical marketing over the past two decades. Last month, the biotech paid $762 million to settle civil and criminal charges of off-label marketing and paying kickbacks (back story). The US Department of Justice found these practices induced physicians to use Amgen (AMGN) medications unnecessarily when lower-cost alternatives were available, causing federal healthcare programs such as Medicare and Medicaid to overpay. We spoke with Osciecki, who wore a wire during numerous meetings with her former Amgen colleagues, about her experience and why she decided to go to the feds…
    Pharmalot: What prompted you to become a whistleblower?
    Osciecki: I didn’t understand all the ins and outs of a qui tam or whistleblower lawsuit. I’d actually gone to the government first to report this activity before I filed this lawsuit. But the morale at the company was extremely low. My morale was low. People were being fired all over the place. This was in 2004. The culture had changed very dramatically after a managerial change. Amgen had been the kind of place where people loved to come to work, but then the management change made it miserable. But there wasn’t necessarily any place better to go in terms of the pharmaceutical industry.
    So people were trying to make the best of it. But I’m a very stubborn person and I wasn’t likely to quit. I felt I may very well be fired as other reps had been. So I knew that if I ever intended to do anything about what I felt was unethical behavior, I had to do it while I was still at the company. I mean there were other things I could do (for a living) even if I got blackballed. I had a master’s (degree). There was a family business.
    Pharmalot: What was the tipping point for you?
    Osciecki: I’d seen a couple of times in the company where all kinds of policies, HR policies, were ignored. One of the things that put me over the top was an unwillingness to enforce some of the HR policies. One person was retaliating against me because I responded to the company after being called about potential discrimination in our work group. I reported that. They sent me a letter saying they investigated it, but they had not done that at all. I felt they were rotten to the core. They didn’t follow their own policies and I was fed up and experiencing retaliation.
    Pharmalot: I see. And what about Aranesp?
    Osciecki: We all knew what they were doing is illegal. The quickest way to get fired was to not hit your numbers and the only way to hit your numbers was to compete as everyone else was doing, which was to sell drugs through illegal mechanisms – promoting off label. [EDITOR’S NOTE: The feds accused Amgen of illegally promoting Aranesp at unapproved doses that were larger and less frequently administered, and also promoted the drug for treating anemia caused by cancer, regardless of whether a patient had been prescribed chemotherapy. The FDA determined this increased the risk of death.]
    Osciecki: There were also the spread marketing techniques (in which Amgen manipulated pricing so that physicians could bill higher reimbursement rates to federal healthcare programs, such as Medicare and Medicaid). I was disgusted with that. It was clear that this (marketing) was not about safety and efficacy. It was all about getting reimbursement levels from Medicare. That’s all that the company cared about. Once we got reimbursement, then all restrictions were off. We could talk about how much more money doctors or their surrogates could make.
    Pharmalot: Can you explain that a little? What wasn’t kosher?
    Osciecki: Two things are not kosher – getting a compendia listing is supposed to be based on a broad overview of the literature and reflect accepted medical practice supported by peer-reviewed journal articles. Amgen had one, 30-patient study, which was not placebo-controlled, and took it to a compendium and convinced them to list it for approved use. The second thing is promoting or advocating for reimbursement of off-label use. And we had a clever way of getting around it. We were able to provide info to physicians in response to unsolicited questions. So we’d show them info on the disease state and we prompted them to ask questions about whether Aranesp could be used for anemia of cancer.
    Amgen knew what the legal requirements were for providing reimbursement of off-label use. But there was not even a published study, just a poster from ASCO (the American Society of Clinical Oncology). That should have been a red flag. It was not peer reviewed. But once it’s in a compendium, they went around to cancer specialists. It was a huge end run around FDA approval.
    Pharmalot: You portray this in the lawsuit as a rather widespread effort…
    Osciecki: There was a national meeting where they rolled out the entire plan. There were also pre-meeting materials and working materials that we all had to read. You know, we’re talking about studies with glossy slides. Everyone had a role in this – marketing managers, scientific liaisons. There was a push to have anemia for cancer added as a reimbursable use of Aranesp. And once the listing was in that compendium, you’d have to get Medicare directors to change coverage documents.
    Pharmalot: And the big competitive threat was (J&J’s) Procit, right?
    Osciecki: We were aware of Procrit studies where patients had died and asked experts who said there was concern about providing (Amgen’s) Epogen in these patients, which could feed the tumor. I knew scientifically there was an unanswered question… Was it really even safe to use an ESA (erythropoiesis-stimulating agent, such as Epogen or Procrit) in patients who were not being treated with chemotherapy? There were large, placebo-controlled trials that had been done with Procrit. It’s almost the same drug as Aranesp and had shown an increased death rate in a controlled group versus a placebo group in anemia of cancer setting. The question was: Why were more patients dying on the drug? It was in the back of my mind that placebo-controlled studies showed a higher death rate and we were pitching a non-placebo controlled study to get a compendia listing and now all sorts of people would be taking it. It was risky.
    Pharmalot: But why did you go to the government before complaining internally?
    Osciecki: I was afraid. I had seen Amgen either punish people who expressed concerns or fired them out right. So I’m not going to risk that by raising this issue. It’s too big. I’m going to provide evidence to the government. Originally, I called and couldn’t get anybody on the phone, but I did get a call back from an agent and set up a meeting at a government building. It was a hole in the wall, a very unimpressive office. This was an OIG agent I met with (from the US Department of Health & Human Services Office of the Inspector General). They weren’t interested in a rogue district manager, though. They were interested in anything that would involve a regional manager or higher officials, or things that took place at regional and national meetings. I showed them evidence and was asked to get more evidence. As part of that, they asked me to wear a wire. I decided that I had to go to a higher authority. I thought the company was rotten to the core.
    Pharmalot: It must have been stressful wearing a wire.
    Osciecki: I did so on 13 different occasions. Sometimes I did it for a full day or multiple days. There were lots of logistics involved. I had to meet agents at various times each day to get new batteries and recordings changed out. It was quite stressful. There were special meeting places. What I was most concerned about was (creating noisy) feedback from the mechanism I wore. At one point, I went through a medical detector at an airport and the wire set it off. But luckily, none of my coworkers were with me.
    There were times I was disappointed that I wasn’t wearing the wire on certain days when I heard certain things said… I also remember that one of my coworkers accused me of being the type of person who would report illegal behavior to the government. So yes, that was stressful. But I knew the financial incentives involved and, as a result, that off-label use was increasing the amount of money that the government and individual people were paying. I knew someone who was paying a $2,000 copayment for one shot. This was a real hardship on people. And I really wanted to stick around and do what I could.

  • This is one of many "bad drugs" that caused cancer in children. Novartis is a flop.
    In the latest instance of a drugmaker being accused of off-label marketing, Novartis has agreed to pay $19.9 million to resolve allegations made by Texas and the federal government that the Elidel eczema drug was illegally marketed to treat infant children, but harmful side effects – including cancer-related risks – were not properly disclosed.
    Texas Attorney General Greg Abbott maintains that evidence indicated Novartis improperly urged physicians to prescribe Elidel to children under two years of age for uses that were never approved by the FDA. In fact, the agency required Novartis to place a Black Box warning on Elidel concerning the risk of cancers in infants. Consequently, the state Medicaid program overpaid for Elidel prescriptions (read his statement).
    The settlement stems from a 2006 lawsuit filed by Donald Galmines, a former Novartis sales rep who worked for the drugmaker for five years in Illinois, according to court documents. Among the improper marketing practices cited, he alleged the drugmaker sponsored a study that Elidel was safe and effective for children younger than two years old, and there was no restriction on its usage, while failing to note safety risks. Novartis issued a press release without noting its funding of the study, the lawsuit states.
    The narrative is familiar. This is, you may recall, one of many such settlements involving drugmakers that have agreed to resolve such charges over marketing practices over the past decade or more. (here is the lawsuit). Novartis, in fact, has been down this past before. Two years ago, the drugmaker paid $422.5 million for illegally promoting its Trileptal epilepsy med for unapproved uses, such as bipolar disorder and neuropathic pain, along with five other drugs – Diovan, Zelnorm, Sandostatin, Exforge and Tekturna (back story). Also in 2010, two units of the big drugmaker – Novartis Vaccines & Diagnostics and Novartis Pharmaceuticals – agreed to pay a $72.5 million fine in order to resolve civil False Claims Act charges over the marketing of the TOBI cystic fibrosis medicine (read here).

    Sentiment: Sell

  • Reply to

    Another DUD

    by smirabella1 Jan 23, 2013 11:35 AM
    cabillhoward cabillhoward Jan 23, 2013 7:11 PM Flag

    LOL you hoping the numbers will be good for Fanapt boy you're living on a wing and a prayer. Little research for you tonight type in Fanapt and CHMP warning, risk outweigh rewards. Don't expect to be happy it's bad news........real bad news for investors of this flop of a drug Fanapt.

  • Reply to

    Novartis - Fanapt - Lanza

    by jennam0677 Jan 14, 2013 12:11 PM
    cabillhoward cabillhoward Jan 22, 2013 11:02 PM Flag

    your comments are stupid

  • Reply to

    Novartis - Fanapt - Lanza

    by jennam0677 Jan 14, 2013 12:11 PM
    cabillhoward cabillhoward Jan 22, 2013 11:01 PM Flag

    Weathergav your assumptions are silly. I am not for gun control and have never owned a gun. I am simply tired of the big political campaign to rid America of guns, it's ludicrous and it's not going to solve Americas school violence. Taking these children off these very strong seratonin inhibitors will.
    There are no more guns today than twenty years ago and we never heard of random and constant violence in schools. The news today, two more shootouts in schools. You can choose to ignore facts because you have a vested interest or you can read the facts and the fact is Lanza has been confirmed by "Business Insider" he was on the violence-linked anti-psychotic drug Fanapt.
    300 million people were prescribed Fanapt, only 500 people were subjects of the clinical trials. Long term use of this drug is not known, fact. We are in trouble in this country and the psychotropic drugs being prescribed to millions of children is what is causing our children to go crazy. I am very good friends with who was voted teacher of the year and we have had long conversations about the drugs her students are being prescribed. Prozac and Ritalin are prescribed to any child diagnosed as hyper. These are hard core drugs that change how your brain works these children's brains are being tampered with at a very early age. Choose to ignore the facts and invest in this company then you are part of it.

    Sentiment: Sell

  • Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. (More...)

    Vanda Pharmaceuticals (VNDA) is a company with a market capitalisation of ~$123 million and a current share price of $4.34. Vanda's share price reached as high as $15.52 in August 2009, a few months after the U.S. FDA (Food and Drug Administration) approval of Fanapt, an anti-psychotic drug for schizophrenia. But the story in the following years has not been so rosy, with a steady decline in the share price, which is now sitting at around about the lowest level in just over three years. Sales from Fanapt have been dissapointing, amid a very crowded market for anti-psychotics, which includes competition from generic anti-psychotics. Despite this, Vanda is still pursuing development of an injectable form of the drug with partner Novartis (NVS) in the U.S., as well as approval of the drug by the EMA (European Medicines Agency). Their other drug in late stage clinical trials is Tasimelteon. Tasimelteon is currently being targeted towards Non-24-Hour Sleep-Wake Disorder (N24HSWD), as well as major depression. In this article I will focus on the former indication, as in this case the drug is in Phase III trials with results expected in late 2012.

    N24HSWD is a type of Circadian Rhythm Sleep Disorder (CSRD). Other such disorders include Shift Work Sleep Disorder, Delayed Phase Sleep Disorder and Jet Lag. So what is circadian rhythm? Circadian rhythm is like our biological or internal clock, and is regulated by a group of cells called the Suprachiasmatic Nucleus in the brain. This group of cells interacts with the Pineal Gland in the brain which releases the hormone melatonin. Melatonin levels can fluctuate. Rising levels of melatonin can contribute to sleepiness. Normally, the rise and fall of melatonin levels that influences the sleep-wake cycle lasts longer than 24 hours. However, the Suprachiasmatic Nucleus also receives signals transmitted by nerves from the back of the eye. These signals are related to the presence or absence of light. In the dark, at night, this group of cells relays a message to the Pineal Gland to release melatonin. In the light, during the day, the opposite happens. These external environmental cues allow the body to be synchronized to a 24 hour period. In people who are totally blind, these environmental cues are absent, and so their internal clock can run a little longer than 24 hours. In fact, their internal clock can run about 15 minutes longer everyday, and is often referred to as a "free-running" circadian rhythm. This means that they will start sleeping later and later every day. Eventually they will be sleeping during the day, and awake during the night. But this will then revert, and they will then start sleeping during the night, and be awake during the day. This cycle can last one-to-four months at a time. Studies have shown that the use of exogenous melatonin in such individuals can result in synchronization or entrainment of these "free-running" circadian rhythms to a 24 hour period, meaning that these individuals are able to sleep in a pattern that is correlated with a normal 24 hour sleep-wake cycle. Tasimeleton is a melatonin receptor agonist. It stimulates the receptors that bind to melatonin, and it does this with higher affinity than melatonin itself. Tasimelteon has Orphan Drug Status for N24HSWD in blind individuals without light perception. Vanda estimates that in the U.S. there are ~65,000 people with this disorder.

    Tasimelteon is a drug that was in-licensed by Vanda from Bristol-Myers Squibb (BMY). Vanda is liable to pay Bristol-Myers Squibb milestone payments of up to $40 million in aggregate. It's interesting although not unusual to note that in this case Bristol-Myers Squibb chose not to pursue full development and commercialisation of the drug themselves. In fact, Fanapt had a similar story before Novartis did an about-face and took control of sales in the U.S. Vanda have also recently in-licensed another early stage drug called VLY-686 from Eli Lily (LLY). Big Pharma out-licensing is done for various reasons, including for the purpose of limiting R&D expenditure, or even offering an additional revenue stream. However the foremost thought in my mind is usually that the company has decided that either the drug is not going to work or that there will not be enough demand for it, but perhaps I'm being too cynical. Having said all that, this of course does not mean that Tasimelteon is worthless. But how is Vanda, a microcap stock, going to develop and commercialise this drug? Well, Vanda received a $200 million milestone payment from partner Novartis after Fanapt was approved, so cash does not appear to be a short-term problem. And as I mentioned before, Phase III trial results are expected in late 2012. However, looking at the recent 10K, I noted that Vanda has a June 2013 deadline by which it must file an NDA (New Drug Application) with the FDA and reach a development and commercialisation third party agreement in a major market country for Tasimelteon. If this is not met, Bristol-Myers Squibb could take full control of the license and future development and commercialisation of the drug themselves. Another concern is that Vanda has yet to reach an agreement with the FDA about how to best interpret the results of the trials. Tasimelteon is also not the first melatonin receptor agonist on the market. That honour goes to Ramelteon (trade name Rozerem), sold by Takeda Pharmaceuticals (TKPHF.PK) from Japan. However, Ramelteon was approved by the FDA for chronic insomnia, a much larger market. Interestingly, Ramelteon was not approved by the EMA, as it did not believe the effect on sleep was significant enough. Vanda has previously run a Phase III trial for Tasimelteon in chronic insomnia, but it appears as though it is no longer pursuing this market. Furthermore, it should be noted that melatonin is widely available in the U.S. as a dietary supplement. In Europe however, melatonin is a regulated drug and is approved for blind individuals with insomnia. Nevertheless, no studies have been done to prove whether melatonin agonists are any better than melatonin itself.

    Besides the results of the Tasimelteon trial, the other significant near-term catalyst for Vanda will be the results of the Fanapt trial for the injectable formulation of the drug. Now despite its downside risks, I do like Tasimelteon, I think there is an unmet medical need for the drug. My thoughts on Fanapt are quite the opposite. Although it is plausible that the trial results in both these instances could be good, I'm not so confident about whether either of these drugs will become a commercial success. Certainly some have argued that Fanapt is already a commercial flop. Furthermore, I'm not confident that Vanda will get Fanapt approved by the EMA. In Vanda's latest earnings call transcript its CEO mentions various issues outlined by the EMA including, "competitive efficacy, cardiac safety and appropriateness of the existing active control maintenance study." Putting all this together, and bearing in mind that Vanda has more cash than its market capitalisation, one could argue that company is undervalued, with near-term catalysts that could swing its share price on the run-up or after. However, I believe that the downside risks are far too great, and that the share price could fall a lot lower than where it already is, particularly looking beyond the next 9-12 months.

    http://seekingalpha.com/author/praveen-jayarajan

    Sentiment: Sell

  • Reply to

    Holder needs to be IMPEACHED

    by dkd83kje9dd0dd Jan 10, 2013 12:48 PM
    cabillhoward cabillhoward Jan 16, 2013 1:28 PM Flag

    Jennam I like you more and more.

  • Reply to

    Novartis - Fanapt - Lanza

    by jennam0677 Jan 14, 2013 12:11 PM
    cabillhoward cabillhoward Jan 16, 2013 1:24 PM Flag

    Finally! Someone out there that knows what the hell this company is responsible for! And to you weathergav keep lying to yourself so you can ignore the fact you're investing in drugs that are ruining our children and this country. Until psychotropics were pushed on children there were NO school shootings. Only a #$%$ would ignore the facts.

  • cabillhoward cabillhoward Jan 16, 2013 12:06 PM Flag

    Yes Lanza was on Fanapt and yes CHMP issued a warning that stated "The risk did not outweigh the rewards" the drug is known to cause psychotic episodes. For those of you that invest in Psychotropic drug companies, do your research, you are investing in the demise of this country. For more information search, " School shootings and Psychotropic Drugs"

    Sentiment: Sell

  • cabillhoward cabillhoward Jan 16, 2013 12:02 PM Flag

    No not delusional and I can even spell which apparently you cannot. Perhaps you should get off the drugs and read the warning issued by CHMP it's easily found online. The warning isn't the only thing Vanda has to worry about now, the clinical trials were insufficient before release of this drug and the drug was only tested on 500 patients before it was released to 300 million citizens in the U.S. Vanda has big trouble ahead.

    Sentiment: Sell

  • On December 13, 2012 one day before the Connecticut shootings, a warning was issued to Vanda Pharmaceutical Inc. the manufacturer of Fanapt, from The Committee for Medicinal Product for Human(CHMP) who advised against marketing authorization and stated the risk surpassed the rewards. Adam Lanza was on Fanapt. Side effects reported were violent outburst and fits of rage.

    The days that followed the elementary school shootings in Connecticut were devastating for this country and only days before Christmas. A Christmas that would never come for a town in mourning after their little children and their teachers were gunned down. It's one of the most heartbreaking moments in this country's history. This isn't the kind of things that happened when I was growing up, teachers and children were not gunned down like animals in our schools. These kind of random acts of violence we see occurring by the hands of children have become common and we need to find answers.

    We must find out why children have become so violent. The answer is actually right in front of our faces but, deliberately kept out of the mainstream media. Ritalin was heavily introduced into the market for children that were hyper and in the 1990's the widespread use of Psychotropic drugs rose 700%
    Every shooter starting from Columbine was taking psychotropic drugs that had known serious side effects including fits of rage. The warnings issued were not only ignored by the Pharmaceutical companies but were deliberately covered up.
    Pharmaceutical companies have conducted fraudulent, painful experiments 0n animals knowing the animal is not a reliable model for a human being. If the drug is considered safe on a primate or other species it's considered safe for humans. This has resulted in disastrous effects. We do not share 100% of the same DNA as a primate therefore a primate should never be used as a human model.
    Primates waste away in sheer terror in laboratories as I write this. The test they will endure will be only used as a cover up for the pharmaceutical companies to shove their dangerous drugs as quickly as possible into the market.

    Data Fabrication is so widespread there is a name for it, in the United States it is called "Dry Labeling" in Japan it's called "Making" false reports are given stating the drug is safe and effective for humans after being tested on primates and other species.

    Novartis the distributer and owner of Fanapt was the company also behind what was called the worst disaster in medical history, baboon and pig hearts removed from the animal and surgically implanted into a human. In many cases these animals were fully conscience in every case both animal and human died. Covance, Huntingdon Life Sciences, are directly connected with Novartis. The USDA violations against animals are shocking. This a story of modern day witchdoctors at it's best. the CEO of Novartis and his staff has never been held accountable. The warning the distributer and manufacturer were issued clearly stated "the risk of taking Fanapt were not worth the rewards" Also treatment or use longer than five weeks on a human was never established. Fanapt was released by these companies knowing it caused psychotic rages. It's not known if Adam Lanza was diagnosed at birth with this mental disorder or if he simply had ADHD and was given a steady stream of drugs and later became schizophrenic.


    These psychotropic drugs were known to cause serious side effects including aggression, and delusion, Hostility, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, delirium, polydipsia psychogenic, impulse-control disorder, and major depression. Demand Vanda, Novartis and all of the companies that distributed these drugs to the children and young adults that shot up our schools, malls, movie theaters where so many have died, be held accountable for their actions.

    Do not allow your children to be forced to take psychotropic drugs under any circumstances this is not going to cure your child. Mineral and chemical deficiencies can be cured. In cases of Dementia it was determined simply adding potassium to the diets of those effected cured the symptoms.
    Testing your child for these deficiencies and supplying them with the necessary nutrients and trace minerals they are missing as well as testing for heavy metals can have the necessary results you are seeking. By refusing to give your child psychotropic drugs you may stop another tragedy.

    These drugs are dangerous and as the result have caused people including our children to become dangerous. Until we all come to the realization this is not about gun control it's about the mis-use of psychotropic drugs being prescribed to us and our children.

    NY is the only state that considered a bill to ban the long term use of psychotropic drugs.

  • On December 13, 2012 one day before the Connecticut shootings, a warning was issued to Vanda Pharmaceutical Inc. the manufacturer of Fanapt, from The Committee for Medicinal Product for Human(CHMP) who advised against marketing authorization and stated the risk surpassed the rewards. Adam Lanza was on Fanapt.

    The days that followed the elementary school shootings in Connecticut were devastating for this country and only days before Christmas. A Christmas that would never come for a town in mourning after their little children and their teachers were gunned down. It's one of the most heartbreaking moments in this country's history. This isn't the kind of things that happened when I was growing up, teachers and children were not gunned down like animals in our schools. These kind of random acts of violence we see occurring by the hands of children have become common and we need to find answers.

    We must find out why children have become so violent. The answer is actually right in front of our faces but, deliberately kept out of the mainstream media. Ritalin was heavily introduced into the market for children that were hyper and in the 1990's the widespread use of Psychotropic drugs rose 700%
    Every shooter starting from Columbine was taking psychotropic drugs that had known serious side effects including fits of rage. The warnings issued were not only ignored by the Pharmaceutical companies but were deliberately covered up.
    Pharmaceutical companies have conducted fraudulent, painful experiments 0n animals knowing the animal is not a reliable model for a human being. If the drug is considered safe on a primate or other species it's considered safe for humans. This has resulted in disastrous effects. We do not share 100% of the same DNA as a primate therefore a primate should never be used as a human model.
    Primates waste away in sheer terror in laboratories as I write this. The test they will endure will be only used as a cover up for the pharmaceutical companies to shove their dangerous drugs as quickly as possible into the market.

    Data Fabrication is so widespread there is a name for it, in the United States it is called "Dry Labeling" in Japan it's called "Making" false reports are given stating the drug is safe and effective for humans after being tested on primates and other species.

    Novartis the distributer and owner of Fanapt was the company also behind what was called the worst disaster in medical history, baboon and pig hearts removed from the animal and surgically implanted into a human. In many cases these animals were fully conscience in every case both animal and human died. This a story of modern day witchdoctors at it's best. the CEO of Novartis and his staff has never been held accountable. The warning the distributer and manufacturer were issued clearly stated "the risk of taking Fanapt were not worth the rewards" Also treatment or use longer than five weeks on a human was never established. Fanapt was released by these companies knowing it caused psychotic rages. It's not known if Adam Lanza was diagnosed at birth with this mental disorder or if he simply had ADHD and was given a steady stream of drugs and later became schizophrenic.


    These psychotropic drugs were known to cause serious side effects including aggression, and delusion, Hostility, paranoia, anorgasmia, confusional state, mania, catatonia, mood swings, panic attack, obsessive-compulsive disorder, delirium, polydipsia psychogenic, impulse-control disorder, and major depression. Demand Vanda, Novartis and all of the companies that distributed these drugs to the children and young adults that shot up our schools, malls, movie theaters where so many have died, be held accountable for their actions.

    Do not allow your children to be forced to take psychotropic drugs under any circumstances this is not going to cure your child. Mineral and chemical deficiencies can be cured. In cases of Dementia it was determined simply adding potassium to the diets of those effected cured the symptoms.
    Testing your child for these deficiencies and supplying them with the necessary nutrients and trace minerals they are missing as well as testing for heavy metals can have the necessary results you are seeking. By refusing to give your child psychotropic drugs you may stop another tragedy.

    These drugs are dangerous and as the result have caused people including our children to become dangerous. Until we all come to the realization this is not about gun control it's about the mis-use of psychotropic drugs being prescribed to us and our children.

    NY is the only state that considered a bill to ban the long term use of psychotropic drugs.

    Sentiment: Sell

AMGN
122.01+0.90(+0.74%)Jul 23 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Facebook, Inc.
NasdaqGSWed, Jul 23, 2014 4:00 PM EDT
Gilead Sciences Inc.
NasdaqGSWed, Jul 23, 2014 3:59 PM EDT